MarketPulse

hepatocellular carcinoma

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Roche Launches Liver Disease Panel With AI Algorithms to Combat Global CLD Crisis

Roche launches Liver Disease Panel with CE-marked LiverPRO algorithm to detect liver fibrosis using only age and blood markers, targeting 1.5 billion CLD patients globally.
RHHBYbiomarker diagnosticshepatocellular carcinoma
GlobeNewswire Inc.GlobeNewswire Inc.··Sapu Nano / Oncotelic Therapeutics

Sapu Nano Advances mTOR Therapy With First Patient in Everolimus IV Trial

Sapu Nano dosed first patient in Phase 1b trial of intravenous everolimus formulation for advanced cancers including breast cancer and renal cell carcinoma.
OTLCbreast cancerneuroendocrine tumors
GlobeNewswire Inc.GlobeNewswire Inc.··Adagene Inc.

Adagene Posts Promising ADG126 Data With $74.5M Cash Runway Into 2028

Adagene reports 29% response rate for ADG126 in colorectal cancer with improved safety profile. Company maintains $74.5M cash reserves extending runway into early 2028.
MRKSNYRHHBYADAGcolorectal cancerclinical trial